ClinicalTrials.gg
Not yet recruitingNCT07909759Updated Nov 2, 2026

Effects of Cervical SNAGs With and Without Thoracic Manipulation on Neck Pain and Disability in Smartphone Users

An interventional study of Cervical SNAGS and thoracic manipulation with conventional physiotherapy and Cervical SNAG Mobilization Alone + Conventional Physiotherapy in Non Specific Neck Pain, sponsored by University of Management and Technology Lahore. Not yet recruiting at 1 site in Pakistan. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment

Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

Non-specific neck pain is a pain and discomfort in the cervical spinal area that arises without trauma, clearly identifiable pathological cause such as fracture infection, nerve root compression, inflammatory disease or serious structural abnormality. Frequent smartphone use in a pathological way forces the user to adopt a compromised posture, gradually resulting in changes to both the postural and musculoskeletal systems. The incidence of non-specific neck pain (NSNP) makes up approximately 25% of all outpatients in general clinics and 12-70% of the general population. According to symptom duration, Chronic non-specific neck pain is usually classified as pain lasting or recurring for > 3 months. Techniques such as SNAG mobilization and thoracic manipulation may also improve posture and cervical biomechanics by restoring normal spinal mobility. The objective of this study will be to compare the effects of Cervical, Sustain Natural Apophyseal Glide with and Without Thoracic Spine Manipulation on Pain, Range of Motion and Neck Disability in Smartphone Users with Non-Specific Neck Pain. Study design will be randomized clinical trial. Evaluation will be done by using NPRS, NDI and smartphone inclinometer. Non-probability convenient sampling will be used and the subjects will be allocated to two groups by random allocation. Group A will receive cervical SNAG and thoracic manipulation along with conventional physiotherapy and Group B will receive cervical SNAGS alone with conventional physiotherapy. Both groups will receive 12 sessions for the period of 4 weeks. Measurements of all the outcome variables will be taken at baseline, 2nd and 4th week. Results will be analyzed by using SPSS 24

02

Conditions studied

  • Non Specific Neck Pain

Browse trials for

Keywords

  • SNAG, Mulligan mobilization, thoracic manipulation, non-specific neck pain, smartphone users, neck pain, range of motion, neck disability
03

In context

Neck Pain

1,269 studies on the registry are indexed under Neck Pain; 259 are open to participants now.

This study's planned enrollment of 60 is above the median of 52 across 1,034 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

University of Management and Technology Lahore is the lead sponsor of 34 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Non-specific neck pain patients aged ≥ 20 to 50 years old (4). Both genders. Mild to moderate neck with NPRS pain score value of between 3/10 - 6/10. Patients with chronic non-specific neck pain (>=12 weeks) Individuals using smartphone for at-least 3-4 hours daily for the last 6 months

Exclusion criteria

Exclusion Criteria:

Any cervical pathology such as cervical fracture, tumor, infection, Inflammatory disease or myelopathy.

Cervical radiculopathy or neurological signs Previous cervical spine surgery Any systemic or rheumatologic disease such as arthritis, ankylosing spondylitis, fibromyalgia or osteoporosis.

Having red flag symptoms such as unexplained weight loss, fever, cancer history, night pain or any vertebral artery insufficiency symptoms.

Any ongoing concurrent treatment such as other physiotherapy, chiropractic treatment or strong analgesic regimens

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Cervical SNAGS and thoracic manipulation with conventional physiotherapy

    Participants in Group A will receive Cervical Sustained Natural Apophyseal Glide (SNAG) mobilization combined with thoracic spine manipulation along with conventional physiotherapy treatment. * Cervical SNAG Mobilization Cervical SNAG mobilization will be applied according to Mulligan's concept in a pain-free direction. The therapist will apply a sustained facet glide while the participant actively performs the restricted cervical movement (flexion, extension, rotation, or side bending). There will be 3 sets of 6-10 repetitions per movement. The hold duration will be 3-5 seconds with the rest interval of 30 seconds between sets. * Thoracic Spine Manipulation High velocity low amplitude (HVLA) thoracic manipulation will be applied to the upper thoracic region (T1-T4/T6) with the participant in prone lying position. Manipulation frequency will be 1-2 thrusts per session and target region will be upper thoracic hypomobile segments.

    Other: Cervical SNAGS and thoracic manipulation with conventional physiotherapy

  • Experimental
    Cervical SNAGS alone with conventional physiotherapy

    Participants in Group B will receive Cervical Sustained Natural Apophyseal Glide (SNAG) mobilization alone along with conventional physiotherapy treatment. Cervical SNAG mobilization will be applied according to Mulligan's concept in a pain-free direction. The therapist will apply a sustained facet glide while the participant actively performs the restricted cervical movement (flexion, extension, rotation, or side bending). There will be 3 sets of 6-10 repetitions per movement. The hold duration will be 3-5 seconds with the rest interval of 30 seconds between sets.

    Other: Cervical SNAG Mobilization Alone + Conventional Physiotherapy

Interventions

  • OtherCervical SNAGS and thoracic manipulation with conventional physiotherapy

    Participants in Group A will receive Cervical Sustained Natural Apophyseal Glide (SNAG) mobilization combined with thoracic spine manipulation along with conventional physiotherapy treatment. * Cervical SNAG Mobilization Cervical SNAG mobilization will be applied according to Mulligan's concept in a pain-free direction. The therapist will apply a sustained facet glide while the participant actively performs the restricted cervical movement (flexion, extension, rotation, or side bending). There will be 3 sets of 6-10 repetitions per movement. The hold duration will be 3-5 seconds with the rest interval of 30 seconds between sets. * Thoracic Spine Manipulation High velocity low amplitude (HVLA) thoracic manipulation will be applied to the upper thoracic region (T1-T4/T6) with the participant in prone lying position. Manipulation frequency will be 1-2 thrusts per session and target region will be upper thoracic hypomobile segments.

  • OtherCervical SNAG Mobilization Alone + Conventional Physiotherapy

    Participants in Group B will receive Cervical Sustained Natural Apophyseal Glide (SNAG) mobilization alone along with conventional physiotherapy treatment. Cervical SNAG mobilization will be applied according to Mulligan's concept in a pain-free direction. The therapist will apply a sustained facet glide while the participant actively performs the restricted cervical movement (flexion, extension, rotation, or side bending). There will be 3 sets of 6-10 repetitions per movement. The hold duration will be 3-5 seconds with the rest interval of 30 seconds between sets

06

What researchers measure

Primary outcomes

  1. NUMERIC PAIN RATING SCALE

    Numeric Rating Scale (NPRS) is most frequently used instruments to measure pain intensity in low back pain (LBP). The 11-point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform ADLs).

    Time frame: baseline and after 4 weeks

  2. The Neck Disability Index (NDI)

    The Neck Disability Index (NDI) is a ten-item questionnaire based on the Oswestry Low Back Pain Index that assesses disability associated with neck pain and whiplash. It is the most widely used and most strongly validated instrument for assessing self-rated disability in patients with neck pain. It has been used effectively in both clinical and research settings in the treatment of this very common problem. (16) There are four items that relate to subjective symptomatology (pain intensity, headache, concentration, sleeping) and six items that relate to activities of daily living (lifting, work, driving, recreation, personal care, reading). The questionnaire requires only 5-10 minutes to complete and score, and requires no special training to administer. A score of less than 4 indicates no disability, 5-14 mild disability, 15-24 moderate disability, 25-34 severe disability, and scores greater than 35 complete disabilities

    Time frame: baseline and after 4 weeks

  3. SMARTPHONE INCLINOMETER

    Cervical range of motion (ROM) is commonly assessed using instruments such as the Universal Goniometer and smartphone-based inclinometers. Cervical range of motion (ROM) in the present study will be measured using a smartphone-based digital inclinometer application. Smartphone inclinometers utilize built-in accelerometer and gyroscope sensors to provide objective angular measurements in degrees. Recent evidence supports their validity and reliability for cervical ROM assessment in both clinical and research settings. A systematic review by Elgueta (18) reported that smartphone applications demonstrated good to excellent reliability and acceptable validity for measuring cervical ROM. Similarly Romero found that smartphone-based applications showed high concurrent validity and excellent intra- and inter-rater reliability for cervical ROM measurements.(19) Furthermore, Huang concluded that smartphone integrated inclinometers provide accurate, reliable, rapid, and convenient assessment o

    Time frame: baseline and after 4 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — The results data collected, de-identified individual participant data will be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: 6 months after the publication of the manuscript.

Access criteria: The data can be requested from the corresponding author.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

Of 696 non-industry interventional studies with no phase under Neck Pain, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 14. This study's planned 2 months is below that.

Counting every sponsor, half of 704 studies reached it within 7 months; a quarter within 3 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2026
First posted
Nov 2, 2026
StartEst.
Oct 27, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07909759
Lead sponsor
University of Management and Technology Lahore
Responsible party
Sponsor
First posted
Nov 2, 2026
Start date
Oct 27, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 2, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion